Comments

HAVN Life Sciences (HAVLF) Stock Price, Quote, News & History

Q: What sector and industry does HAVN Life Sciences (HAVLF) operate in?

HAVN Life Sciences is in the Healthcare sector and Biotechnology industry. They are listed on the OTCEM.

HAVLFOTCEM

Logo brought to you by Benzinga Data

Trade with Public

$0.00010

Last update: Nov 5, 2:52 PM

Overview

News Short Interest

Edge Rankings

Key Statistics

Open

Volume / Avg.

0 / 3.76K

Day Range

- - -

52 Wk Range

0.00 - 0.01

Market Cap

$1.47K

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent HAVN Life Sciences Inc News

EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves

Jamaica introduces its first legal psilocybin products in pharmacies through a historic partnership between PATOO and Fontana Pharmacy.

Javier Hasse

HAVN Life Closes First Tranche Of July Financing By ABO, Details On Amendments And Debt Shares Issuance

Biotech psychedelics company HAVN Life Sciences Inc. (OTC: HAVLF) recently closed the initial tranche of its financing pact with innovative fund Alpha Blue Ocean (“ABO”), previously announced on July 21, 2022.

Lara Goldstein

Learn About HAVN Life's New Shares Consolidation, What Changes And What Remains

A key player in the biotech-meets-psychedelics space, HAVN Life Sciences Inc.

Lara Goldstein

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Key Statistics

Open

Volume / Avg.

0 / 3.76K

Day Range

- - -

52 Wk Range

0.00 - 0.01

Market Cap

$1.47K

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

N/A

Industry

N/A

HAVN Life Sciences Inc is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs, the development of natural health products, and innovative therapies to support brain health and enhance the capabil...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy HAVN Life Sciences (HAVLF) stock?

You can purchase shares of HAVN Life Sciences (OTCEM:HAVLF) through any online brokerage.

View our list of the best stock brokerages

Who are HAVN Life Sciences (HAVLF) competitors?

There are no as such competitors for HAVN Life Sciences.

What is the forecast, or price target, for HAVN Life Sciences (HAVLF) stock?

There is no analysis for HAVN Life Sciences to provide a consensus price target.

What is the current price for HAVN Life Sciences (HAVLF)?

The stock price for HAVN Life Sciences (OTCEM: HAVLF) is $0.0001 last updated November 5, 2025 at 2:52 PM EST.

Does HAVN Life Sciences (HAVLF) pay a dividend?

There are no upcoming dividends for HAVN Life Sciences.

When is HAVN Life Sciences (OTCEM:HAVLF) reporting earnings?

HAVN Life Sciences does not have any upcoming earnings scheduled.

Is HAVN Life Sciences (HAVLF) going to split?

There is no upcoming split for HAVN Life Sciences.

What sector and industry does HAVN Life Sciences (HAVLF) operate in?

HAVN Life Sciences is in the Healthcare sector and Biotechnology industry. They are listed on the OTCEM.